News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ascletis, Inc. Adds Support to $100 Million in Startup Capital


7/21/2011 2:30:52 PM

July 21, 2011 -- Ascletis, a US-China drug development startup, announced new support from the two cities in which it will do business – Hangzhou, China, and Research Triangle Park, US. One feature of the new agreements is clear: Ascletis will house a US-based R&D center in the Research Triangle’s Hamner Institutes. Beyond that, there aren’t many specifics in the agreements, beyond access to the networks of The Hamner and Hangzhou Hi-Tech Industry Development Zone. More details....

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES